Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in Experimental Autoimmune Encephalomyelitis

Journal of Neuroimmunology

Volumn 215, Issue 1-2, 2009, Pages 73-83

  Aharoni, Rina ^a   Aizman, Elizabeta ^a   Fuchs, Ora ^a   Arnon, Ruth ^a   Yaffe, David ^a   Sarig, Rachel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Experimental Autoimmune Encephalomyelitis; Glatiramer acetate; Multiple Sclerosis; Myoblasts; Neurons; Progenitor cells

Indexed keywords

BETA 3 TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLATIRAMER; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUBULIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALS; BIOLOGICAL MARKERS; CELL MOVEMENT; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOBLASTS, SKELETAL; PEPTIDES; RATS; STEM CELLS;

EID: 70349738085     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.08.009     Document Type: Article

References (53)

1. Aharoni R., Teitelbaum D., Sela M., and Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 94 (1997) 10821-10826
2. Aharoni R., Teitelbaum D., Sela M., and Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J Neuroimmunol 91 (1998) 135-146
3. Aharoni R., Teitelbaum D., Leitner O., Meshorer A., Sela M., and Arnon R. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc Natl Acad Sci U S A 97 (2000) 11472-11477
4. Aharoni R., Teitelbaum D., Arnon R., and Sela M. Copolymer 1 inhibits manifestations of graft rejection. Transplantation 72 (2001) 598-605
5. Aharoni R., Kayhan B., Eilam R., Sela M., and Arnon R. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci U S A 100 (2003) 14157-14162
6. Aharoni R., Arnon R., and Eilam R. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J Neurosci 25 (2005) 8217-8228
7. Aharoni R., Eilam R., Domev H., Labunskay G., Sela M., and Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci U S A 102 (2005) 19045-19050
8. Aharoni R., Herschkovitz A., Eilam R., Blumberg-Hazan M., Sela M., Bruck W., and Arnon R. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105 (2008) 11358-11363
9. Alessandri G., Pagano S., Bez A., Benetti A., Pozzi S., Iannolo G., Baronio M., Invernici G., Caruso A., Muneretto C., Bisleri G., and Parati E. Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364 (2004) 1872-1883
10. Arnon R., and Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A 101 Suppl 2 (2004) 14593-14598
11. Chen C.P., Kiel M.E., Sadowski D., and McKinnon R.D. From stem cells to oligodendrocytes: prospects for brain therapy. Stem Cell Rev 3 (2007) 280-288
12. Daniela F., Vescovi A.L., and Bottai D. The stem cells as a potential treatment for neurodegeneration. Methods Mol Biol 399 (2007) 199-213
13. Einstein O., Grigoriadis N., Mizrachi-Kol R., Reinhartz E., Polyzoidou E., Lavon I., Milonas I., Karussis D., Abramsky O., and Ben-Hur T. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198 (2006) 275-284
14. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., and Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 61 (2007) 209-218
15. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., and Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28 (2000) 41-51
16. Fuchs E., Tumbar T., and Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 116 (2004) 769-778
17. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., and Uccelli A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61 (2007) 219-227
18. Hess D.C., and Borlongan C.V. Stem cells and neurological diseases. Cell Prolif 41 Suppl 1 (2008) 94-114
19. Hommes O.R. Can we pass from the experimental to the clinical phase in MS stem cell research?. J Neurol Sci 265 (2008) 136-139
20. Jaenisch R., and Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132 (2008) 567-582
21. Jin K., Sun Y., Xie L., Peel A., Mao X.O., Batteur S., and Greenberg D.A. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 24 (2003) 171-189
22. Karussis D., and Kassis I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin Neurol Neurosurg 110 (2008) 889-896
23. Kawauchi S., Beites C.L., Crocker C.E., Wu H.H., Bonnin A., Murray R., and Calof A.L. Molecular signals regulating proliferation of stem and progenitor cells in mouse olfactory epithelium. Dev Neurosci 26 (2004) 166-180
24. Konigsberg I.R. Clonal analysis of myogenesis. Science 140 (1963) 1273-1284
25. Krabbe C., Zimmer J., and Meyer M. Neural transdifferentiation of mesenchymal stem cells-a critical review. Apmis 113 (2005) 831-844
26. Lassmann H. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. J Neurol Sci 233 (2005) 83-86
27. Matysiak M., Stasiolek M., Orlowski W., Jurewicz A., Janczar S., Raine C.S., and Selmaj K. Stem cells ameliorate EAE via an indoleamine 2, 3-dioxygenase (IDO) mechanism. J Neuroimmunol 193 (2008) 12-23
28. Mignon L., Vourc'h P., Romero-Ramos M., Osztermann P., Young H.E., Lucas P.A., and Chesselet M.F. Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats. J Comp Neurol 491 (2005) 96-108
29. Murer M.G., Yan Q., and Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63 (2001) 71-124
30. Neuhaus O., Farina C., Yassouridis A., Wiendl H., Then Bergh F., Dose T., Wekerle H., and Hohlfeld R. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci U S A 97 (2000) 7452-7457
31. Newman M.P., Feron F., and Mackay-Sim A. Growth factor regulation of neurogenesis in adult olfactory epithelium. Neuroscience 99 (2000) 343-350
32. Payne N., Siatskas C., and Bernard C.C. The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun 31 (2008) 288-294
33. Pencea V., Bingaman K.D., Wiegand S.J., and Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 21 (2001) 6706-6717
34. Pluchino S., and Martino G. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J Neurol Sci 233 (2005) 117-119
35. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., and Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 (2003) 688-694
36. Politi L.S., Bacigaluppi M., Brambilla E., Cadioli M., Falini A., Comi G., Scotti G., Martino G., and Pluchino S. Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 25 (2007) 2583-2592
37. Riley C.P., Cope T.C., and Buck C.R. CNS neurotrophins are biologically active and expressed by multiple cell types. J Mol Histol 35 (2004) 771-783
38. Romero-Ramos M., Vourc'h P., Young H.E., Lucas P.A., Wu Y., Chivatakarn O., Zaman R., Dunkelman N., el-Kalay M.A., and Chesselet M.F. Neuronal differentiation of stem cells isolated from adult muscle. J Neurosci Res 69 (2002) 894-907
39. Rosser A.E., Zietlow R., and Dunnett S.B. Stem cell transplantation for neurodegenerative diseases. Curr Opin Neurol 20 (2007) 688-692
40. Sarig R., Mezger-Lallemand V., Gitelman I., Davis C., Fuchs O., Yaffe D., and Nudel U. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum Mol Genet 8 (1999) 1-10
41. Sarig R., Baruchi Z., Fuchs O., Nudel U., and Yaffe D. Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells 24 (2006) 1769-1778
42. Schaefer B.C., Schaefer M.L., Kappler J.W., Marrack P., and Kedl R.M. Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo. Cell Immunol 214 (2001) 110-122
43. Schlegel P.G., Aharoni R., Chen Y., Chen J., Teitelbaum D., Arnon R., Sela M., and Chao N.J. A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo. Proc Natl Acad Sci U S A 93 (1996) 5061-5066
44. Schultz S.S., Abraham S., and Lucas P.A. Stem cells isolated from adult rat muscle differentiate across all three dermal lineages. Wound Repair Regen 14 (2006) 224-231
45. Steffel J., Wernig M., Knauf U., Kumar S., Wiestler O.D., Wernig A., and Brustle O. Migration and differentiation of myogenic precursors following transplantation into the developing rat brain. Stem Cells 21 (2003) 181-189
46. Tamaki T., Okada Y., Uchiyama Y., Tono K., Masuda M., Wada M., Hoshi A., Ishikawa T., and Akatsuka A. Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage. Stem Cells 25 (2007) 2283-2290
47. Teitelbaum D., Meshorer A., Hirshfeld T., Arnon R., and Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1 (1971) 242-248
48. Vourc'h P., Romero-Ramos M., Chivatakarn O., Young H.E., Lucas P.A., El-Kalay M., and Chesselet M.F. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochem Biophys Res Commun 317 (2004) 893-901
49. Wagers A.J., and Weissman I.L. Plasticity of adult stem cells. Cell 116 (2004) 639-648
50. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci U S A 61 (1968) 477-483
51. Yaffe D. Cellular aspects of muscle differentiation in vitro. Curr Top Dev Biol 4 (1969) 37-77
52. Yaffe D., and Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270 (1977) 725-727
53. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., and Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761